Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jbt Marel (JBTM) Liabilities and Shareholders Equity (2016 - 2025)

Jbt Marel (JBTM) has 16 years of Liabilities and Shareholders Equity data on record, last reported at $8.2 billion in Q4 2025.

  • For Q4 2025, Liabilities and Shareholders Equity rose 139.93% year-over-year to $8.2 billion; the TTM value through Dec 2025 reached $32.6 billion, up 181.79%, while the annual FY2025 figure was $8.2 billion, 139.93% up from the prior year.
  • Liabilities and Shareholders Equity reached $8.2 billion in Q4 2025 per JBTM's latest filing, roughly flat from $8.2 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $8.3 billion in Q2 2025 and bottomed at $1.8 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $3.6 billion, with a median of $2.6 billion recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: fell 4.77% in 2021, then skyrocketed 206.78% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $2.1 billion in 2021, then rose by 20.65% to $2.6 billion in 2022, then rose by 4.91% to $2.7 billion in 2023, then increased by 25.95% to $3.4 billion in 2024, then soared by 139.93% to $8.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $8.2 billion in Q4 2025, $8.2 billion in Q3 2025, and $8.3 billion in Q2 2025.